rs73406330

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001363711.2(DUOX2):​c.2334+10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0885 in 1,613,860 control chromosomes in the GnomAD database, including 9,543 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2930 hom., cov: 32)
Exomes 𝑓: 0.082 ( 6613 hom. )

Consequence

DUOX2
NM_001363711.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.53

Publications

7 publications found
Variant links:
Genes affected
DUOX2 (HGNC:13273): (dual oxidase 2) The protein encoded by this gene is a glycoprotein and a member of the NADPH oxidase family. The synthesis of thyroid hormone is catalyzed by a protein complex located at the apical membrane of thyroid follicular cells. This complex contains an iodide transporter, thyroperoxidase, and a peroxide generating system that includes this encoded protein and DUOX1. This protein is known as dual oxidase because it has both a peroxidase homology domain and a gp91phox domain. [provided by RefSeq, Jul 2008]
DUOX2 Gene-Disease associations (from GenCC):
  • thyroid dyshormonogenesis 6
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • familial thyroid dyshormonogenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 15-45105633-G-A is Benign according to our data. Variant chr15-45105633-G-A is described in ClinVar as Benign. ClinVar VariationId is 260321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.34 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DUOX2NM_001363711.2 linkc.2334+10C>T intron_variant Intron 18 of 33 ENST00000389039.11 NP_001350640.1
DUOX2NM_014080.5 linkc.2334+10C>T intron_variant Intron 18 of 33 NP_054799.4 Q9NRD8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DUOX2ENST00000389039.11 linkc.2334+10C>T intron_variant Intron 18 of 33 1 NM_001363711.2 ENSP00000373691.7 X6RAN8
DUOX2ENST00000603300.1 linkc.2334+10C>T intron_variant Intron 18 of 33 1 ENSP00000475084.1 Q9NRD8
DUOX2ENST00000558383.1 linkn.4065+10C>T intron_variant Intron 12 of 16 5

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
22991
AN:
152010
Hom.:
2915
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.344
Gnomad AMI
AF:
0.0461
Gnomad AMR
AF:
0.111
Gnomad ASJ
AF:
0.0850
Gnomad EAS
AF:
0.0513
Gnomad SAS
AF:
0.0557
Gnomad FIN
AF:
0.0759
Gnomad MID
AF:
0.120
Gnomad NFE
AF:
0.0748
Gnomad OTH
AF:
0.127
GnomAD2 exomes
AF:
0.0946
AC:
23745
AN:
250904
AF XY:
0.0886
show subpopulations
Gnomad AFR exome
AF:
0.348
Gnomad AMR exome
AF:
0.120
Gnomad ASJ exome
AF:
0.0813
Gnomad EAS exome
AF:
0.0503
Gnomad FIN exome
AF:
0.0686
Gnomad NFE exome
AF:
0.0736
Gnomad OTH exome
AF:
0.0869
GnomAD4 exome
AF:
0.0820
AC:
119845
AN:
1461732
Hom.:
6613
Cov.:
33
AF XY:
0.0805
AC XY:
58507
AN XY:
727182
show subpopulations
African (AFR)
AF:
0.359
AC:
12025
AN:
33476
American (AMR)
AF:
0.121
AC:
5405
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0791
AC:
2067
AN:
26134
East Asian (EAS)
AF:
0.0554
AC:
2200
AN:
39700
South Asian (SAS)
AF:
0.0595
AC:
5136
AN:
86250
European-Finnish (FIN)
AF:
0.0680
AC:
3633
AN:
53388
Middle Eastern (MID)
AF:
0.0920
AC:
530
AN:
5764
European-Non Finnish (NFE)
AF:
0.0748
AC:
83173
AN:
1111912
Other (OTH)
AF:
0.0940
AC:
5676
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
6174
12347
18521
24694
30868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3278
6556
9834
13112
16390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.152
AC:
23056
AN:
152128
Hom.:
2930
Cov.:
32
AF XY:
0.148
AC XY:
11038
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.344
AC:
14269
AN:
41434
American (AMR)
AF:
0.111
AC:
1704
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0850
AC:
295
AN:
3472
East Asian (EAS)
AF:
0.0512
AC:
265
AN:
5176
South Asian (SAS)
AF:
0.0562
AC:
271
AN:
4824
European-Finnish (FIN)
AF:
0.0759
AC:
805
AN:
10602
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.0749
AC:
5091
AN:
68008
Other (OTH)
AF:
0.131
AC:
277
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
895
1790
2686
3581
4476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0984
Hom.:
464
Bravo
AF:
0.163
Asia WGS
AF:
0.113
AC:
393
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Thyroid dyshormonogenesis 6 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.63
DANN
Benign
0.74
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73406330; hg19: chr15-45397831; API